Patent details
EP2992903 Title: COMBINATION OF A NALOXOL-PEG CONJUGATE AND AN OPIOID AGONIST
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2992903
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP15188944.1
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- Sweden (SE)
- Publications:
Dates
- Filing date:
- 29/09/2011
- Grant date:
- 15/07/2020
- EP Publication Date:
- 09/03/2016
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 01/10/2020
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 15/07/2020
- EP B1 Publication Date:
- 15/07/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 28/09/2031
- Lapsed By Expiration Date:
- Patent Validated Date:
- 16/10/2020
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 05/11/2025
- Name:
- Grünenthal GmbH
- Address:
- Zieglerstraße 6, 52078, Aachen, Germany (DE)
- From:
- 05/11/2025
- Name:
- Nektar Therapeutics
- Address:
- 455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94185, United States of America (US)
Historical Applicant/holder
- From:
- 15/07/2020
- To:
- 05/11/2025
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 SÖDERTÄLJE, Sweden (SE)
- From:
- 15/07/2020
- To:
- 05/11/2025
- Name:
- Nektar Therapeutics
- Address:
- 455 Mission Bay Boulevard Suite 100, San Francisco, CA 94158, United States of America (US)
Agent
- Name:
- ir. M.F.J.M. Ketelaars c.s.
- From:
- 15/10/2020
- Address:
- NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- ASLUND, Bengt Leonard
- Address:
- 151 85 Södertälje, Sweden (SE)
2
- Name:
- AURELL, Carl-Johan
- Address:
- 151 85 Södertälje, Sweden (SE)
3
- Name:
- BOHLIN, Martin Hans
- Address:
- 151 85 Södertälje, Sweden (SE)
4
- Name:
- SEBHATU, Tesfai
- Address:
- 151 85 Södertälje, Sweden (SE)
5
- Name:
- YMEN, Bo Ingvar
- Address:
- 151 85 Södertälje, Sweden (SE)
6
- Name:
- HEALY, Eric Thomas
- Address:
- San Francisco, CA 94158, United States of America (US)
7
- Name:
- JENSEN, David Richard
- Address:
- San Francisco, CA 94158, United States of America (US)
8
- Name:
- JONAITIS, David Thomas
- Address:
- West Lafayette, IN 47906-1076, United States of America (US)
9
- Name:
- PARENT, Stephan
- Address:
- West Lafayette, IN 47906-1076, United States of America (US)
10
- Name:
- LECHUGA-BALLESTEROS, David
- Address:
- San Jose, CA 95124, United States of America (US)
Priority
- Priority Patent Number:
- 388501 P
- Priority Date:
- 30/09/2010
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 45/06; A61P 39/00; C07D 489/04; A61K 47/60;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 46/25
- Publication date:
- 12/11/2025
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 43/20
- Publication date:
- 21/10/2020
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 29/20
- Publication date:
- 14/08/2020
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
1
- Issue number:
- 202229
- Publication date:
- 20/07/2022
- Description:
- Inventor(s) changed
2
- Issue number:
- 202224
- Publication date:
- 15/06/2022
- Description:
- Inventor(s) changed
3
- Issue number:
- 202223
- Publication date:
- 08/06/2022
- Description:
- Document reprinted after correction (B8, B9)
4
- Issue number:
- 202222
- Publication date:
- 01/06/2022
- Description:
- Inventor(s) changed
5
- Issue number:
- 202029
- Publication date:
- 15/07/2020
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202501807A
- Date Registered:
- 05/11/2025
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. F.A. Geurts c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
1
- Name:
- Nektar Therapeutics
- Address:
- 455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94185, United States of America (US)
2
- Name:
- Grünenthal GmbH
- Address:
- Zieglerstraße 6, 52078, Aachen, Germany (DE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 30/09/2026
- Annual Fee Number:
- 16
- Annual Fee Amount:
- 1000 Euro
- Last Annual Payment Date:
- 14/08/2025
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 900 Euro
- Payer:
- Computer Patent Annuities Limited (CPA)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 15/10/2020 | Outgoing Correspondence | Letter no formal defects | 1 | /5/8/3/6/7/0800576385/docs/ep15188944.1_0_372716l271.pdf | ||
| 01/10/2020 | Claims | First filed claims | 2 | /5/8/3/6/7/0800576385/docs/ep15188944.1_1_claims20201001081552452.pdf |